Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (331-340 of 363) with videos related to

Pageof 37
Sort By:
The Journal of Nutrition|August 2, 2001
Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescentsM L Neuhouser, C L Rock, A L Eldridge, et al.
AIDS (London, England)|June 21, 2001
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individualsA I Veldkamp, G J Weverling, J M Lange, et al.
Antiviral Research|July 1, 1997
Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapiesM D de Jong, C A Boucher, D A Cooper, et al.
American Journal of Epidemiology|October 15, 1994
Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter StudyP J Veugelers, K A Page, B Tindall, et al.
AIDS (London, England)|March 9, 2000
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDSA E Grulich, X Wan, M G Law, et al.
The Journal of Infectious Diseases|July 9, 1999
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremiaJ J Zaunders, P H Cunningham, A D Kelleher, et al.
HIV Medicine|August 19, 2008
Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndromeN Voirin, J-P Routy, D Smith, et al.
AIDS Research and Human Retroviruses|September 18, 2001
Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapineK Suzuki, G R Kaufmann, M Mukaide, et al.
AIDS (London, England)|August 10, 2000
A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patientsK Ruxrungtham, E D Kroon, C Ungsedhapand, et al.
AIDS (London, England)|December 31, 1997
Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study GroupG J Stewart, L J Ashton, R A Biti, et al.
Pageof 37

Showing results (331-340 of 363) with videos related to

Sort By:
Pageof 37
The Journal of Nutrition|August 2, 2001
Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescentsM L Neuhouser, C L Rock, A L Eldridge, et al.
AIDS (London, England)|June 21, 2001
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individualsA I Veldkamp, G J Weverling, J M Lange, et al.
Antiviral Research|July 1, 1997
Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapiesM D de Jong, C A Boucher, D A Cooper, et al.
American Journal of Epidemiology|October 15, 1994
Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter StudyP J Veugelers, K A Page, B Tindall, et al.
AIDS (London, England)|March 9, 2000
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDSA E Grulich, X Wan, M G Law, et al.
The Journal of Infectious Diseases|July 9, 1999
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremiaJ J Zaunders, P H Cunningham, A D Kelleher, et al.
HIV Medicine|August 19, 2008
Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndromeN Voirin, J-P Routy, D Smith, et al.
AIDS Research and Human Retroviruses|September 18, 2001
Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapineK Suzuki, G R Kaufmann, M Mukaide, et al.
AIDS (London, England)|August 10, 2000
A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patientsK Ruxrungtham, E D Kroon, C Ungsedhapand, et al.
AIDS (London, England)|December 31, 1997
Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study GroupG J Stewart, L J Ashton, R A Biti, et al.
Pageof 37